DK0415522T3 - Fremgangsmåde til reducering af krystalstørrelsen af ondansetron-hydrochlorid-dihydrat - Google Patents
Fremgangsmåde til reducering af krystalstørrelsen af ondansetron-hydrochlorid-dihydratInfo
- Publication number
- DK0415522T3 DK0415522T3 DK90307044.9T DK90307044T DK0415522T3 DK 0415522 T3 DK0415522 T3 DK 0415522T3 DK 90307044 T DK90307044 T DK 90307044T DK 0415522 T3 DK0415522 T3 DK 0415522T3
- Authority
- DK
- Denmark
- Prior art keywords
- reducing
- hydrochloride dihydrate
- ondansetron hydrochloride
- crystal size
- size
- Prior art date
Links
- FELGMEQIXOGIFQ-UHFFFAOYSA-N Ondansetron Chemical compound CC1=NC=CN1CC1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-UHFFFAOYSA-N 0.000 title abstract 3
- 229960005343 ondansetron Drugs 0.000 title abstract 3
- 239000013078 crystal Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002425 crystallisation Methods 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Otolaryngology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Glass Compositions (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898914804A GB8914804D0 (en) | 1989-06-28 | 1989-06-28 | Process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0415522T3 true DK0415522T3 (da) | 1994-09-19 |
Family
ID=10659180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90307044.9T DK0415522T3 (da) | 1989-06-28 | 1990-06-27 | Fremgangsmåde til reducering af krystalstørrelsen af ondansetron-hydrochlorid-dihydrat |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5622720A (da) |
| EP (1) | EP0415522B1 (da) |
| JP (1) | JP3093242B2 (da) |
| KR (1) | KR0182789B1 (da) |
| AT (1) | ATE110380T1 (da) |
| AU (1) | AU637110B2 (da) |
| CA (1) | CA2019944C (da) |
| DE (1) | DE69011786T2 (da) |
| DK (1) | DK0415522T3 (da) |
| ES (1) | ES2060045T3 (da) |
| GB (1) | GB8914804D0 (da) |
| HK (1) | HK44495A (da) |
| HU (1) | HU208009B (da) |
| IE (1) | IE64715B1 (da) |
| IL (1) | IL94888A (da) |
| NZ (1) | NZ234267A (da) |
| RU (1) | RU2002745C1 (da) |
| SA (1) | SA90110025B1 (da) |
| UA (1) | UA18249A (da) |
| ZA (1) | ZA905002B (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020115707A1 (en) * | 2001-01-11 | 2002-08-22 | Rami Lidor-Hadas | Process for preparing pure ondansetron hydrochloride dihydrate |
| CA2475123A1 (en) * | 2002-02-19 | 2003-08-28 | Teva Pharmaceutical Industries Ltd. | Desolvating solvates of atorvastatin hemi-calcium |
| EP1485344A1 (en) | 2002-03-28 | 2004-12-15 | Synthon B.V. | Venlafaxine besylate |
| DK1499623T3 (da) * | 2002-04-29 | 2007-10-08 | Teva Gyogyszerg Ar Zartkoeruee | Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on |
| US20050131045A1 (en) * | 2002-04-30 | 2005-06-16 | Judith Aronhime | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them |
| US20060083759A1 (en) * | 2002-07-17 | 2006-04-20 | Aleksander Resman | Stabilization of the profile of release of active substances from a formulation |
| JP5690461B2 (ja) * | 2002-11-15 | 2015-03-25 | ヘルシン ヘルスケア ソシエテ アノニム | 化学療法誘導嘔吐を治療するためのパロノセトロン |
| US8598219B2 (en) | 2003-01-30 | 2013-12-03 | Helsinn Healthcare Sa | Liquid pharmaceutical formulations of palonosetron |
| JO2735B1 (en) | 2003-01-30 | 2013-09-15 | هيلسين هيلث كير أس ايه. | Liquid pharmaceutical formations of balloonosterone |
| TWI355936B (en) * | 2003-02-18 | 2012-01-11 | Helsinn Healthcare Sa | Uses of palonosetron hydrochloride |
| US7390503B1 (en) | 2003-08-22 | 2008-06-24 | Barr Laboratories, Inc. | Ondansetron orally disintegrating tablets |
| US20060167072A1 (en) * | 2004-01-30 | 2006-07-27 | Helsinn Healthcare Sa | Liquid pharmaceutical formulations of palonosetron |
| US7288660B2 (en) | 2004-05-07 | 2007-10-30 | Taro Pharmaceutical Industries Limited | Process for preparing ondansetron hydrochloride dihydrate having a defined particle size |
| ZA200707469B (en) * | 2005-02-23 | 2008-11-26 | Teva Pharma | Rasagiline formulations of improved content uniformity |
| CA2600011C (en) * | 2005-02-23 | 2015-11-10 | Teva Pharmaceutical Industries Ltd. | Rasagiline formulations of improved content uniformity |
| TWI367212B (en) * | 2006-10-24 | 2012-07-01 | Helsinn Healthcare Sa | Dosage forms of palonosetron hydrochloride having improved stability and bioavailability |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR920003064B1 (ko) * | 1984-01-25 | 1992-04-13 | 글락소 그룹 리미티드 | 헤테로시클릭 화합물의 제조방법 |
| US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
| US4845115A (en) * | 1986-12-17 | 1989-07-04 | Glaxo Group Limited | Method of medical treatment |
| DK185489A (da) * | 1988-04-22 | 1989-10-23 | Duphar Int Res | Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse |
| US5344658A (en) * | 1989-06-28 | 1994-09-06 | Glaxo Group Limited | Process and composition using ondansetron |
-
1989
- 1989-06-28 GB GB898914804A patent/GB8914804D0/en active Pending
-
1990
- 1990-06-27 ZA ZA905002A patent/ZA905002B/xx unknown
- 1990-06-27 KR KR1019900009540A patent/KR0182789B1/ko not_active IP Right Cessation
- 1990-06-27 HU HU904015A patent/HU208009B/hu unknown
- 1990-06-27 DK DK90307044.9T patent/DK0415522T3/da active
- 1990-06-27 IE IE233390A patent/IE64715B1/en not_active IP Right Cessation
- 1990-06-27 ES ES90307044T patent/ES2060045T3/es not_active Expired - Lifetime
- 1990-06-27 CA CA002019944A patent/CA2019944C/en not_active Expired - Lifetime
- 1990-06-27 RU SU904830462A patent/RU2002745C1/ru active
- 1990-06-27 AT AT90307044T patent/ATE110380T1/de not_active IP Right Cessation
- 1990-06-27 DE DE69011786T patent/DE69011786T2/de not_active Expired - Lifetime
- 1990-06-27 EP EP90307044A patent/EP0415522B1/en not_active Expired - Lifetime
- 1990-06-27 JP JP02169655A patent/JP3093242B2/ja not_active Expired - Lifetime
- 1990-06-27 IL IL9488890A patent/IL94888A/en unknown
- 1990-06-27 AU AU57874/90A patent/AU637110B2/en not_active Expired
- 1990-06-27 NZ NZ234267A patent/NZ234267A/en unknown
- 1990-06-27 UA UA4830462A patent/UA18249A/uk unknown
- 1990-08-18 SA SA90110025A patent/SA90110025B1/ar unknown
-
1995
- 1995-03-23 HK HK44495A patent/HK44495A/xx not_active IP Right Cessation
- 1995-06-07 US US08/472,881 patent/US5622720A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69011786D1 (de) | 1994-09-29 |
| EP0415522A1 (en) | 1991-03-06 |
| IL94888A (en) | 1995-03-15 |
| JPH0395178A (ja) | 1991-04-19 |
| ES2060045T3 (es) | 1994-11-16 |
| RU2002745C1 (ru) | 1993-11-15 |
| HUT54140A (en) | 1991-01-28 |
| EP0415522B1 (en) | 1994-08-24 |
| IE64715B1 (en) | 1995-08-23 |
| UA18249A (uk) | 1997-12-25 |
| SA90110025B1 (ar) | 2001-03-24 |
| IL94888A0 (en) | 1991-04-15 |
| JP3093242B2 (ja) | 2000-10-03 |
| HU904015D0 (en) | 1990-12-28 |
| AU5787490A (en) | 1991-01-03 |
| NZ234267A (en) | 1992-11-25 |
| KR910000709A (ko) | 1991-01-30 |
| GB8914804D0 (en) | 1989-08-16 |
| AU637110B2 (en) | 1993-05-20 |
| US5622720A (en) | 1997-04-22 |
| CA2019944C (en) | 2000-05-09 |
| ATE110380T1 (de) | 1994-09-15 |
| KR0182789B1 (ko) | 1999-10-15 |
| HK44495A (en) | 1995-03-31 |
| HU208009B (en) | 1993-07-28 |
| IE902333A1 (en) | 1991-01-16 |
| CA2019944A1 (en) | 1990-12-28 |
| ZA905002B (en) | 1991-12-24 |
| IE902333L (en) | 1990-12-28 |
| DE69011786T2 (de) | 1994-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0415522T3 (da) | Fremgangsmåde til reducering af krystalstørrelsen af ondansetron-hydrochlorid-dihydrat | |
| BE882530A (fr) | Procede et dispositif pour la fabrication de couvertures de livre, de chemises, de brochures et analogues et produits ainsi obtenus | |
| ES8300758A1 (es) | Un procedimiento para la preparacion de nuevos pirazimil-1,2,4 oxadiazol-5-onas. | |
| FR2669635B1 (fr) | Procede de fabrication d'hydroxymethylfurfural (hmf) du purete elevee. | |
| JPS51149480A (en) | Servo device for n umerical control | |
| ES2109735T3 (es) | Composiciones adhesivas activables por humedad. | |
| DE68917003D1 (de) | Verfahren zur Herstellung von Halbleiterbauelementen, die gegen Musterverunreinigungen geschützt sind. | |
| ZA922504B (en) | Novel 2-spirocyclopropyl 4-acylcephems and processes for the preparation thereof | |
| DK0508191T3 (da) | Fremgangsmåde til fremstilling af 1-carbamoyl-pyrazoler | |
| NO905012L (no) | Fremgangsmaate til fremstilling av cefemer, oksacefemer ogkarbacefemer og 3-sulfonyloksy-substituerte cefemer, oksacefemer og karbacefemer som utgangsprodukt ved fremgangsmaaten. | |
| DE287063T1 (de) | Schaltung zum automatischen regeln des verstaerkung-bandbreite-produktes von operationsverstaerkern. | |
| JPS51126841A (en) | Reinforced light-fiber | |
| JPS525700A (en) | The process for production of silicon nitride | |
| JPS52137944A (en) | Time supervisory system of input output non-synchronous singnal | |
| JPS5240287A (en) | Sequence controller | |
| JPS53100562A (en) | Apparatus for separating aligning disk-shaped articles | |
| JPS51123064A (en) | Forming process of bonding-pad area | |
| JPS5225388A (en) | Apparatus for changing the direction of goods being conveyed | |
| JPS5277593A (en) | Temperature compensating circuit of semiconductor strain meter | |
| JPS5216779A (en) | Total weight control system of conveyed articles | |
| JPS53141371A (en) | Treatment of polymeric material | |
| JPS51120302A (en) | Process for controlling turbine | |
| DE3576498D1 (de) | 2-sulfamoyl-1h-indole-derivate zur behandlung von hohem intraocularem druck. | |
| JPS5353633A (en) | 4,4'-(phenylenebismethyleneamino)-diacetophenone and process for preparatioof the same | |
| JPS51125219A (en) | Process for preparation of 2- (silylamino)alkanenitrile |